NVOS Price Today: Novo Integrated Sciences Stock Update
If you’ve looked up the NVOS price recently, you’ve probably noticed something strange: every site seems to show a different number. That’s not a bug in your search. Novo Integrated Sciences, Inc. (NVOS) is a thinly traded over-the-counter stock, and its price can move sharply on very little volume while some data feeds lag behind the actual market.
This guide walks through where NVOS trades right now, why the quote changes depending on where you look, and what’s actually been pushing the price around through 2026.
What Is NVOS Stock?
NVOS is the ticker symbol for Novo Integrated Sciences, Inc., a Bellevue, Washington based healthcare company. Through its Canadian and U.S. subsidiaries, Novo runs physiotherapy clinics, rehabilitation programs, and eldercare services, and it also operates a medical technology arm that includes telehealth and remote patient monitoring. It isn’t a clinical-stage biotech waiting on a single drug trial result. It’s an operating healthcare business with real revenue, and that changes how you should read anything written about its stock price.
For more on the company’s business lines, this NVOS stock overview breaks down each segment in detail.
NVOS Price: Current Snapshot
Numbers on a micro-cap OTC stock go stale within hours, so treat this table as a structural reference, not a live quote. Always confirm the exact figure on OTC Markets or your broker’s feed before acting on it.
| Metric | Detail |
| Ticker | NVOS |
| Company | Novo Integrated Sciences, Inc. |
| Exchange | OTC Markets (previously Nasdaq Capital Market) |
| Recent price range | Roughly $0.001 to $0.006 per share through mid-2026 |
| Market capitalization | Roughly $60,000 to $75,000 |
| Shares outstanding | About 19.7 million, post reverse split |
| Revenue (trailing 12 months) | Around $13.3 million |
| Net income | Negative, around -$16 million trailing 12 months |
| 52-week range | A fraction of a cent up to roughly $0.06 |
| Reverse splits | 1-for-10 in February 2021; 1-for-10 in November 2023 |
| Sector | Healthcare services and medical technology |
These figures come from public market data trackers as of mid-2026 and shift as new trades, filings, and share counts come in. Don’t treat them as a live price feed.
Why the NVOS Price Looks Different on Every Site
This is the most common source of confusion, and it isn’t a data error. A few things are happening at once.
First, NVOS barely trades. On a day with a few thousand shares changing hands, one small trade can swing the last-quoted price by double digits in percentage terms. Second, some financial sites cache quotes and only refresh them every few hours, so you might be looking at Tuesday’s close on a Thursday afternoon without realizing it, visit more.
Third, and this trips up a lot of older articles, NVOS has gone through two reverse splits. A chart or a headline written before November 2023 is describing a completely different share count than what exists today, and mixing pre-split and post-split numbers makes the price look far more dramatic than it is.
For a longer breakdown of why this stock jumps around so much even on quiet days, this look at NVOS stock volatility covers the mechanics in more depth.
What’s Actually Moving the NVOS Price
A handful of factors tend to matter more than broad market sentiment for a stock like this.
Dilution risk: Small healthcare companies that are burning cash often raise money by issuing new shares, warrants, or convertible notes. Every round dilutes existing holders, and it can cap the stock’s upside even when the underlying business is doing fine operationally.
Subsidiary and partnership news: Novo periodically announces agreements through its healthcare subsidiaries, covering clinical services and international partnerships. These headlines can cause a short, sharp price spike that fades once the news cycle moves on to something else.
Exchange status: Trading on OTC Markets instead of Nasdaq changes who’s even allowed to buy the stock. Many institutional funds and some brokerages won’t touch OTC names at all, which limits demand no matter how the business is performing.
Retail sentiment: With a low share price and, at times, a thin float, NVOS attracts message-board and social trading activity that can move the price as much as any fundamental does. It’s worth checking that chatter alongside the numbers. This rundown of what traders are saying about NVOS and this NVOS Stocktwits sentiment read are both useful companion reads before you form an opinion.
From Nasdaq to Penny Stock: A Short History
Novo used to trade on the Nasdaq Capital Market. In February 2024, it received notice that its shares had failed to hold the required $1.00 minimum bid price for 30 straight trading days. The company was given a compliance period, missed it, and was issued a delisting determination. Novo appealed to a Nasdaq hearing panel, but the stock ultimately moved to OTC Markets, where it trades today.
This wasn’t the company’s first brush with a low share price. It carried out 1-for-10 reverse splits in both February 2021 and November 2023, both aimed at meeting exchange price requirements at the time. If you want the full mechanics of how those splits worked and what ratios were used, this NVOS reverse split history lays it out step by step.
How to Check the Real NVOS Price Yourself
Rather than trusting the first number a search engine hands you, run through this quick checklist.
- Pull the live quote directly from OTC Markets or your broker’s app, not a cached search result.
- Check whether the number is split-adjusted. Older articles and charts often aren’t, and that alone explains most of the wild price differences you’ll see.
- Read the company’s most recent SEC filings for cash position and share count. These move the real story more than a single day’s price action does.
- Cross-check recent coverage and community sentiment through a source like this comprehensive NVOS overview alongside the primary filings, rather than relying on one page alone.
Is the NVOS Price Worth Watching for Investors?
That’s not a question anyone else can answer for you, and it’s worth saying plainly. NVOS carries the risk profile common to OTC micro-cap healthcare stocks: thin trading volume, a history of shareholder dilution, and an exchange status that limits who can even hold it. None of that means the underlying business can’t improve. It does mean that any specific price target you find, including the ranges in this article, should be treated as a rough sketch rather than something to plan around.
If you’re weighing a position, spend more time on cash burn, dilution history, and exchange status than on any single forecast number. For a fuller data breakdown alongside the price discussion here, this NVOS price and analysis page is a good next stop, and the NVOS stock forecast covers the bull and bear scenarios in more detail.
FAQs
What is the NVOS price today?
It changes constantly given how thinly the stock trades, and it has recently sat in the fraction-of-a-cent range. Always confirm the live figure on OTC Markets or your broker rather than relying on a cached number from a search result.
Why is NVOS stock so cheap?
Novo Integrated Sciences went through two 1-for-10 reverse splits (2021 and 2023) and was delisted from Nasdaq in 2024 for failing to hold a $1.00 minimum bid price. It now trades on OTC Markets, where micro-cap prices tend to sit well under a dollar.
Is NVOS still listed on Nasdaq?
No. It received a delisting determination in 2024 and now trades over the counter.
Why does the NVOS price differ between financial sites?
Because of thin trading volume, cached or infrequently updated quotes, and confusion between pre-split and post-split share counts on older charts and articles.
Has NVOS done a reverse stock split before?
Yes, twice. A 1-for-10 split in February 2021 and another 1-for-10 split in November 2023, both intended to meet exchange price requirements.
What does Novo Integrated Sciences actually do?
It provides multidisciplinary primary healthcare services, including physiotherapy, rehabilitation, and eldercare, plus a medical technology division covering telehealth and remote patient monitoring.
Conclusion
The NVOS price is a moving target, and for good reason. It’s a thinly traded OTC stock with a reverse-split history, a 2024 Nasdaq delisting behind it, and quotes that can look wildly different depending on when and where you check them. None of that is a data error. It’s just what happens with a micro-cap healthcare name that trades off-exchange.
Before you act on any number you see, whether it’s from this page or anywhere else, confirm the live price directly, check whether it’s split-adjusted, and read the company’s own filings for the details that actually move the business forward. This article is for information only and isn’t financial or investment advice.
